We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Denied: AstraZeneca Loses Seroquel Exclusivity Appeal
An appeals court has sided with the FDA in its high-profile fight with AstraZeneca (AZ), saying the agency had every right last year to deny AZ another extension of exclusivity rights for its anti-psychotic Seroquel.